• OPEN AN ACCOUNT
Indian Indices
Nifty
24,768.35 -86.70
(-0.35%)
Sensex
81,185.58 -296.28
( -0.36%)
Bank Nifty
55,961.95 -188.75
( -0.34%)
Nifty IT
35,301.65 -180.05
( -0.51%)
Global Indices
Nasdaq
44,167.41 -314.88
(-0.71%)
Dow Jones
6,364.11 -19.79
(-0.31%)
Hang Seng
41,114.76 460.06
(1.13%)
Nikkei 225
9,132.81 -4.13
(-0.05%)
Forex
USD-INR
86.92 0.29
(0.33%)
EUR-INR
100.47 -0.57
(-0.57%)
GBP-INR
115.97 -0.14
(-0.12%)
JPY-INR
0.59 0.00
(0.14%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
101.444166
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
95.71
409218.58
EPS(TTM)
Face Value()
Div & Yield %
17.82
1
0.94
 

Genus Prime Infra reports consolidated nil net profit/loss in the December 2024 quarter
Feb 06,2025
Genus Prime Infra reported no net profit/loss in the quarter ended December 2024 as against net profit of Rs 0.01 crore during the previous quarter ended December 2023. Sales rose 20.00% to Rs 0.06 crore in the quarter ended December 2024 as against Rs 0.05 crore during the previous quarter ended December 2023.

ParticularsQuarter Ended
Dec. 2024Dec. 2023% Var.
Sales0.060.05 20
OPM %020.00 -
PBDT00.01 -100
PBT00.01 -100
NP00.01 -100